NDLI: Familial breast cancer: an investigation into the outcome of treatment for early stage disease

Please wait, while we are loading the content...

The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) – Results of an international collaborative study

Mutations of the 'minor' mismatch repair gene MSH6 in typical and atypical hereditary nonpolyposis colorectal cancer

Café-au-lait spots and early onset colorectal neoplasia: a variant of HNPCC?

Chemotherapy resistant ovarian cancer in carriers of an hMSH2 mutation?

Desmoid tumour in familial adenomatous polyposis. A review of literature

Preventive measures in Peutz-Jeghers syndrome

Instructions for authors

Familial Cancer : Volume 1, Issue 1, March 2001

Familial breast cancer: an investigation into the outcome of treatment for early stage disease

Content Provider	Springer Nature Link
Author	Eccles, Diana Simmonds, Peter Goddard, Jonathan Coultas, Marie Hodgson, Shirley Lalloo, Fiona Evans, Gareth Haites, Neva
Copyright Year	2001
Abstract	The purpose of this study was to retrospectively compare the outcomes of treatment in 304 women with familial and sporadic breast cancer to clarify the options for the primary management of familial breast cancer. The majority of women were consecutively ascertained on the basis of either breast cancer diagnosed at age < 40 years or bilateral breast cancer. In addition, known BRCA1 mutation carriers were identified through the genetics services in participating centres. These patients were subdivided into those with a significant family history of breast cancer or known BRCA1 mutation (FH+) and those with no significant family history (FH−). There were no significant differences in age, surgical treatment or adjuvant treatment between the two groups, but there were significantly more women whose nodal status was unknown in the FH+ group. Ipsilateral recurrence occurred in 22.2% of FH+ patients compared with 24.1% of FH− patients (p = 0.774) who underwent breast conserving surgery. There was a striking excess of contralateral breast cancers in the FH+ group (35.9% v 16%, p = 0.0007), with a cumulative risk of contralateral cancer of 36% at 10 years. This was reflected in a non-significant trend toward worse relapse free survival in the FH+ group (p = 0.0563), but no difference was observed in overall survival between the two patient groups (p = 0.142). Similarly, for patients with known BRCA1 mutations, contralateral recurrence occurred more frequently, but other outcomes were not significantly different from the FH− group. Breast conserving treatment is not associated with an increased risk of local recurrence in women with familial breast cancer and the prognosis of these women appears to be similar to that of young women with apparently sporadic breast cancer. However, the risk of contralateral breast cancer is significant in the FH+ group and should be considered in planning primary treatment and follow up.
Starting Page	65
Ending Page	72
Page Count	8
File Format	PDF
ISSN	13899600
Journal	Familial Cancer
Volume Number	1
Issue Number	2
e-ISSN	15737292
Language	English
Publisher	Kluwer Academic Publishers
Publisher Date	2001-01-01
Publisher Place	Dordrecht
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Human Genetics Oncology Epidemiology Counselling
Content Type	Text
Resource Type	Article
Subject	Genetics Cancer Research Genetics (clinical) Oncology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Commentary on Eccles et al.: Familial breast cancer: an investigation into the outcome of treatment for early stage disease

Inflammatory bowel disease in Ashkenazi Jews: implications for familial colorectal cancer

Knowledge about breast cancer risk factors and hereditary breast cancer among early-onset breast cancer survivors

MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch National Study (MRISC)

Familial cancer database: a clinical aide-mémoire

Familial Cancer (special issue) Breast Cancer Treatment and Genetics

Familial pancreatic carcinoma in Jews

Population-based study of familial medullary thyroid cancer

Hereditary breast cancer in Jews

Familial breast cancer: an investigation into the outcome of treatment for early stage disease

Similar Documents

Commentary on Eccles et al.: Familial breast cancer: an investigation into the outcome of treatment for early stage disease

Inflammatory bowel disease in Ashkenazi Jews: implications for familial colorectal cancer

Knowledge about breast cancer risk factors and hereditary breast cancer among early-onset breast cancer survivors

MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch National Study (MRISC)

Familial cancer database: a clinical aide-mémoire

Familial Cancer (special issue) Breast Cancer Treatment and Genetics

Familial pancreatic carcinoma in Jews

Population-based study of familial medullary thyroid cancer

Hereditary breast cancer in Jews

Familial breast cancer: an investigation into the outcome of treatment for early stage disease